Previous Close | 8.61 |
Open | 8.45 |
Bid | 6.00 x 800 |
Ask | 10.13 x 800 |
Day's Range | 8.45 - 9.00 |
52 Week Range | 6.00 - 14.40 |
Volume | |
Avg. Volume | 112,554 |
Market Cap | 272.653M |
Beta (5Y Monthly) | 1.75 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.75 |
Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 20.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for ALPN
Revolution Medicines, Inc. (RVMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
SEATTLE, June 07, 2022--Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the appointment of industry veteran Andrew S. Sandler, M.D., as its Chief Medical Officer. Dr. Sandler joins Alpine from Kiadis Pharma, a Sanofi Company, where he was Chief Medical Officer. Dr. Sandler’s anticipated start date is August 17, 2022.